Liver function tests: Uses, results, and more
Liver function tests can help doctors determine whether a person has liver damage and what might be causing it. Learn about the tests and what the results mean here.
Related Articles
Subscribe to our email newsletter
Subscribe to receive our free quarterly newsletters, journal publication alerts, and other relevant content.
Hema Now: Episode 18: Myeloma Genetics, CAR-T, and Emerging Immunotherapies
Rafael Fonseca, Consultant, Division of Hematology/Oncology, Mayo Clinic, uncovers the biology, diagnosis & management of multiple myeloma.
COMy 2025: Diagnosis Delays in Amyloid Light-Chain Amyloidosis
A new study presented at COMy 2025 reveals that patients with amyloid light-chain amyloidosis still face significant delays in diagnosis, often leading to severe cardiac…
COMy 2025: Senescence Biomarkers Predict Frailty and Survival in Myeloma
New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.
Subscribe to our email newsletter
Subscribe to receive our free quarterly newsletters, journal publication alerts, and other relevant content.
Blood Test Offers Breakthrough in Heart Disease Treatment
A groundbreaking study has introduced a novel, image-based blood test that could significantly enhance the way doctors manage and personalise treatment for coronary artery disease…
COMy 2025: Infection Risk High with Bispecific Antibodies in Myeloma
New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma receiving bispecific antibodies targeting CD3/BCMA and…
Hema Now: Episode 17: What Drives Change in Leukaemia Cells?
Paolo Gallipoli, Clinical Reader, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London joins the podcast
Review of the 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
THE 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city of…
Minimal Residual Disease: Predicting and Preventing Relapse in Myeloma
In the evolving landscape of haematologic cancers, the concept of minimal residual disease, also known as measurable residual disease…